Empagliflozin
Reduce the risk of cardiovascular death and hospitalization for heart failure in adults, Reduce the risk of cardiovascular death in adults with type 2 diabetes and established..., Improve glycemic control in adults and pediatric patients aged 10 years and older with...
Indications
- Reduce the risk of cardiovascular death and hospitalization for heart failure in adults
- Reduce the risk of cardiovascular death in adults with type 2 diabetes and established...
- Improve glycemic control in adults and pediatric patients aged 10 years and older with...
Adult dosing
- initial dose: dose: 10; unit: mg; route: PO; interval: once daily in the morning; fixed: true; labelExcerpt: Recommended dosage is 10 mg once daily in the morning, taken with or without food
- maintenance glycemic control: dose: 25; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: For additional glycemic control, dosage may be increased to 25 mg in patients tolerating JARDIANCE
Pediatric dosing
- initial dose pediatric: dose: 10; unit: mg; route: PO; interval: once daily in the morning; fixed: true; labelExcerpt: Pediatric patients aged 10 years and older Glycemic control in type 2 diabetes mellitus 10 mg orally once daily in the morning, taken with or without food.
- maintenance glycemic control ped: dose: 25; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: For additional glycemic control, may increase to 25 mg orally once daily in patients tolerating 10 mg once daily.
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- No dose adjustment recommended for patients with hepatic impairment.
Contraindications
- Hypersensitivity to empagliflozin
- Patients on dialysis
Clinical pearls
- Assess renal function before initiation; not recommended if eGFR <30 mL/min/1.73 m2.
- Correct volume depletion before starting therapy.
- Monitor for signs of ketoacidosis, urosepsis, and genital mycotic infections.
- Temporarily discontinue for at least 3 days prior to scheduled surgery.
Source and review
- DailyMed label (empagliflozin, JARDIANCE), Set ID 942a82a4-cbbd-4e44-9965-8d03f767912b, effective 2023-07-24. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties